Bedaquiline (BDQ) and delamanid (DLM) are two newly approved anti-TB drugs and are both well tolerated. However, the combined effects of these two drugs have not been studied. Combining these two drugs, together with other anti-TB drugs, may improve outcomes for people with MDR-TB.
Regimen
Bedaquiline - Delamanid with MBT for MDR
Compounds in Regimen
Description
Trial Associations